Company Filing History:
Years Active: 2020-2023
Title: Christopher John Le Page: Innovator in Antibody Technology
Introduction
Christopher John Le Page is a notable inventor based in Slough, GB. He has made significant contributions to the field of antibody technology, holding a total of 4 patents. His work focuses on methods to enhance the efficacy of recombinant antibody molecules.
Latest Patents
Le Page's latest patents include innovative methods for increasing the percentage of monomeric antibody Fab-dsFv multimeric species. One of his inventions provides a method characterized by holding the composition of antibody molecules at a temperature between 30 to 60°C for at least one hour, in the presence of a reducing agent. Another patent outlines a method of monomerization of recombinant antibody molecules, which involves treating the composition with a denaturant such as urea or Guanidine hydrochloride, also in the presence of a reducing agent.
Career Highlights
Throughout his career, Christopher John Le Page has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Sprl and UCB Biopharma Srl. His expertise in antibody technology has positioned him as a valuable asset in the industry.
Collaborations
Le Page has collaborated with notable professionals in his field, including Sam Philip Heywood and Gavin Barry Wild. These collaborations have further enriched his contributions to antibody research and development.
Conclusion
Christopher John Le Page is a distinguished inventor whose work in antibody technology has led to significant advancements in the field. His innovative methods and collaborations continue to influence the biopharmaceutical industry.